API CAS 63074-08-8 Terazosin Hydrochloride Terazosin HCl

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 8/gram
Request Sample
Diamond Member Since 2019

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
Experienced Team
The supplier has 12 foreign trading staff(s) and 10 staff(s) with over 6 years of overseas trading experience
In-stock Capacity
The supplier has In-stock capacity
Fast Delivery
The supplier can deliver the goods within 15 days
to see all verified strength labels (12)
  • API CAS 63074-08-8 Terazosin Hydrochloride Terazosin HCl
  • API CAS 63074-08-8 Terazosin Hydrochloride Terazosin HCl
  • API CAS 63074-08-8 Terazosin Hydrochloride Terazosin HCl
  • API CAS 63074-08-8 Terazosin Hydrochloride Terazosin HCl
  • API CAS 63074-08-8 Terazosin Hydrochloride Terazosin HCl
  • API CAS 63074-08-8 Terazosin Hydrochloride Terazosin HCl
Find Similar Products
  • Overview
  • Description
  • COA
  • Application & Funtion
  • Company
Overview

Basic Info.

Model NO.
SENTIAN-Terazosin Hcl
Certification
ISO 9001, FDA
Suitable for
Adult
State
White Powder
Purity
>99%
OEM/ODM
Yes
MOQ
50g
Sample
5-10g
Shelf Life
2 Years
Boiling Point
664.5ºC
Chemical Formula
C19h26cln5o4
CAS
63074-08-8
Transport Package
1kg/ Bag, 25kg/Drum
Specification
99%
Trademark
SENTIAN
Origin
China
Production Capacity
500kg Per Month

Product Description


 

Description

product name Terazosin HCl
CAS NO. 63074-08-8
Specification 99%
Appearance white powder
Package 10G/Bag,50g/Bag
MOQ 50G


Terazosin hydrochloride is an organic compound with the chemical formula C19H26ClN5O4. It is an antihypertensive and genitourinary drug that can be used to treat benign prostatic hyperplasia and hypertension. It can be used alone or in combination with other antihypertensive drugs such as diuretics or α1-adrenergic blockers.
 

COA

 

Items Standards Results
Appearance white powder Complies
Specification 99% 99.20%
Loss on Drying ≤ 5.0% Complies
Heavy Metal ≤ 10.0 mg/kg Complies
Pb ≤ 2.0 mg/kg Complies
As ≤ 1.0 mg/kg Complies
Hg ≤ 0.1 mg/kg Complies
Total Plate Count ≤ 1000cfu/g Complies
Yeast&Mold ≤ 100cfu/g Complies
E.coil Negative Negative
Salmonella Negative Negative
Conclusion: in conformity with the enterprise standard

 

Application & Funtion


Indications
It can be used to treat benign prostatic hyperplasia and hypertension. It can be used alone or in combination with other antihypertensive drugs such as diuretics or α1-adrenergic blockers.

Usage and Dosage
Usual dosage for adults: The initial dose is 1 mg before bedtime. After 1 or 2 weeks, the daily dose can be doubled to achieve the desired effect. The usual maintenance dose is 2 to 4 mg once a day. Symptoms are significantly improved after 2 weeks of administration. The maximum dose is 10 mg.
 

Company

API CAS 63074-08-8 Terazosin Hydrochloride Terazosin HClAPI CAS 63074-08-8 Terazosin Hydrochloride Terazosin HClAPI CAS 63074-08-8 Terazosin Hydrochloride Terazosin HClAPI CAS 63074-08-8 Terazosin Hydrochloride Terazosin HClAPI CAS 63074-08-8 Terazosin Hydrochloride Terazosin HClAPI CAS 63074-08-8 Terazosin Hydrochloride Terazosin HCl

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier